Clinical trials recruiting for Kidney cancer
27
Recruiting trials
28
US states with sites
11
Countries
15%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 4 |
| Florida | 4 |
| Maryland | 4 |
| New York | 4 |
| Massachusetts | 3 |
| Missouri | 3 |
| North Carolina | 3 |
| Pennsylvania | 3 |
| Texas | 3 |
| Colorado | 2 |
| Indiana | 2 |
| Iowa | 2 |
Top cities
New York, New York 3Boston, Massachusetts 2Houston, Texas 2Los Angeles, California 2Orange, California 2Pittsburgh, Pennsylvania 2St Louis, Missouri 2Aitkin, Minnesota 1Alliance, Ohio 1Aurora, Colorado 1
Self-screener
Recruiting trials
- A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- A Study of VET3-TGI in Patients With Solid Tumors
- A Study of a Side Effects and Resource Navigation Program for People With Cancer
- A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
- Brodalumab in the Treatment of Immune-Related Adverse Events
- Designing Visual Tools to Enhance Cancer Surgeon Decision-making
- Distance-Based Exercise to Preserve Function and Prevent Disability
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
- Ex VIvo DEtermiNed Cancer Therapy
- FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis
- Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
- Integrated Cancer Repository for Cancer Research
- Ivonescimab in the Treatment of Multiple Advanced Tumors
- LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
- Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)
- Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Measuring Oncological Value of Exercise and Statin
- Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
- Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Preop Laxatives in Robotic Urologic Surgery
- Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Related conditions
Trials recruiting for Kidney cancer often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234Melanoma 487Lung cancer 2180Colorectal cancer 1359Breast cancer 2239Head and neck cancer 62Bladder cancer 59Pancreatic cancer 870Ovarian cancer 118Sarcoma 48
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Kidney cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.